ELV

NYSE

Elevance Health, Inc.

Health Care, Managed Health Care

$394.20

close 7 Aug 2026

+35.56%

52-week change

$85.48B

market cap

$274.84

$436.24

52-week range

Valuation

Market cap$85.48B

P/E (TTM / 5y avg)17.45x17.49x

Forward P/E (FY2026 / FY2027)14.51x13.30x

PEG (TTM / fwd)13.841.59

P/S (TTM)0.43x

P/B1.90x

EV/EBITDA (TTM)—

FCF yield (TTM)7.36%

Cash flow & dividend

FCF (TTM)$6.29B

FCF per share (TTM)$29.00

FCF margin (TTM)3.13%

Dividend yield (indicated / 5y avg)1.75%1.42%

Annualized dividend$6.88

Payout ratio (EPS / FCF)30.29%—

Growth & quality

Revenue YoY, latest Q+1.40%

Diluted EPS YoY, latest Q-13.08%

Operating margin (TTM)2.71%

Net margin (TTM)2.47%

ROE (latest FY)12.90%

Net debt / EBITDA (TTM)—

Interest coverage (TTM)—

Price

+7.27%+1.42%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +10.32%10Y CAGR +9.66%

Diluted EPS

5Y CAGR +6.99%10Y CAGR +10.39%

FCF per share

5Y CAGR -17.96%10Y CAGR +0.77%

Operating cash flow

5Y CAGR -16.69%10Y CAGR +0.18%

Free cash flow

5Y CAGR -19.97%10Y CAGR -1.18%

Dividends per share

5Y CAGR +12.66%10Y CAGR +10.96%

Payout ratio

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR -2.10%10Y CAGR -1.67%

Earnings

Street estimates, not SEC filings

Next / Q3 FY26

Date19 Oct 2026bmo

EPS estimate$4.70

Revenue estimate$49.67B

Last reported

Date—

EPS——

Revenue——